Labyrinthine vasodilators.
D018663:Adrenergic Agents / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D007758:Ear, Inner / Q000098:blood supply* / Q000187:drug effects / Q000294:innervation; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D009420:Nervous System / Q000187:drug effects*; D009539:Nicotinic Acids / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010992:Plethysmography, Impedance; D012039:Regional Blood Flow / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents
D018663:Adrenergic Agents; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D002800:Cholinesterase Inhibitors; D009539:Nicotinic Acids; D010276:Parasympatholytics; D010277:Parasympathomimetics; D014665:Vasodilator Agents; D000804:Angiotensin II; D006632:Histamine; D001920:Bradykinin